atc_level_01_code,atc_level_01_name,atc_level_02_code,atc_level_02_name,atc_level_03_code,atc_level_03_name,atc_level_04_code,atc_level_04_name,atc_level_04_note,atc_level_05_code,atc_level_05_name,atc_level_05_note,DDD_inhalepowder,DDD_inhalesolution,DDD_O,DDD_P,DDD_R,unit_inhalepowder,unit_inhalesolution,unit_O,unit_P,unit_R
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA01,demeclocycline,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA02,doxycycline,NA,NA,NA,0.1,0.1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA03,chlortetracycline,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA04,lymecycline,NA,NA,NA,0.6,0.6,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA05,metacycline,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA06,oxytetracycline,NA,NA,NA,1,1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA07,tetracycline,NA,NA,NA,1,1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA08,minocycline,NA,NA,NA,0.2,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA09,rolitetracycline,NA,NA,NA,NA,0.35,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA10,penimepicycline,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA11,clomocycline,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA12,tigecycline,NA,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA13,eravacycline,NA,NA,NA,NA,0.14,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA14,sarecycline,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA15,omadacycline,NA,NA,NA,0.3,0.1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA20,combinations of tetracyclines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01A,TETRACYCLINES,J01AA,Tetracyclines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The tetracyclines have different DDDs due to kinetic differences.  The use of tetracyclines in long-term, low dose treatment of acne is not taken into account in the assignment of DDDs.",J01AA56,"oxytetracycline, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01B,AMPHENICOLS,J01BA,Amphenicols,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01BA01,chloramphenicol,NA,NA,NA,3,3,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01B,AMPHENICOLS,J01BA,Amphenicols,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01BA02,thiamphenicol,NA,NA,NA,1.5,1.5,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01B,AMPHENICOLS,J01BA,Amphenicols,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01BA52,"thiamphenicol, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA01,ampicillin,NA,NA,NA,2,6,2,NA,NA,g,g,g
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA02,pivampicillin,NA,NA,NA,1.05,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA03,carbenicillin,NA,NA,NA,NA,12,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA04,amoxicillin,NA,NA,NA,1.5,3,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA05,carindacillin,NA,NA,NA,4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA06,bacampicillin,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA07,epicillin,NA,NA,NA,2,2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA08,pivmecillinam,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA09,azlocillin,NA,NA,NA,NA,12,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA10,mezlocillin,NA,NA,NA,NA,6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA11,mecillinam,NA,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA12,piperacillin,NA,NA,NA,NA,14,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA13,ticarcillin,NA,NA,NA,NA,15,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA14,metampicillin,NA,NA,NA,1.5,1.5,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA15,talampicillin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA16,sulbenicillin,NA,NA,NA,NA,15,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA17,temocillin,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA18,hetacillin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA19,aspoxicillin,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CA,Penicillins with extended spectrum,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The esters, for instance pivampicillin and pivmecillinam, have a higher bioavailability and thus a lower DDD than the corresponding non-ester compounds.The DDDs for some of the compounds, for instance carbenicillin, piperacillin, ticarcillin and sulbenicillin, are based on the dosages used for narrow indications, i.e. life threatening infections.",J01CA51,"ampicillin, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE01,benzylpenicillin,NA,NA,NA,NA,3.6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE02,phenoxymethylpenicillin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE03,propicillin,NA,NA,NA,0.9,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE04,azidocillin,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE05,pheneticillin,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE06,penamecillin,NA,NA,NA,1.05,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE07,clometocillin,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE08,benzathine benzylpenicillin,Expressed as benzylpenicillin,NA,NA,NA,3.6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE09,procaine benzylpenicillin,NA,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE10,benzathine phenoxymethylpenicillin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CE,Beta-lactamase sensitive penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Benzylpenicillin and phenoxymethylpenicillin have different DDDs due to differences in indications, route of administration and bioavailability.  The DDDs for the combination of benzylpenicillin and procaine penicillin is based on the treatment of syphilis, see list of DDDs for combination products, www.whocc.no.",J01CE30,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01CF01,dicloxacillin,NA,NA,NA,2,2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01CF02,cloxacillin,NA,NA,NA,2,2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01CF03,meticillin,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01CF04,oxacillin,NA,NA,NA,2,2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01CF05,flucloxacillin,NA,NA,NA,2,2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CF,Beta-lactamase resistant penicillins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01CF06,nafcillin,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CG,Beta-lactamase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sulbactam is based on its use together with ampicillin, usually in a dose ratio of 1:2 respectively.",J01CG01,sulbactam,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CG,Beta-lactamase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sulbactam is based on its use together with ampicillin, usually in a dose ratio of 1:2 respectively.",J01CG02,tazobactam,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sultamicillin, a prodrug for sulbactam and ampicillin, is lower than the corresponding DDD for the ordinary combination due to higher bioavailability.",J01CR01,ampicillin and beta-lactamase inhibitor,Refers to ampicillin,NA,NA,NA,6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sultamicillin, a prodrug for sulbactam and ampicillin, is lower than the corresponding DDD for the ordinary combination due to higher bioavailability.",J01CR02,amoxicillin and beta-lactamase inhibitor,Refers to amoxicillin,NA,NA,1.5,3,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sultamicillin, a prodrug for sulbactam and ampicillin, is lower than the corresponding DDD for the ordinary combination due to higher bioavailability.",J01CR03,ticarcillin and beta-lactamase inhibitor,Refers to ticarcillin,NA,NA,NA,15,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sultamicillin, a prodrug for sulbactam and ampicillin, is lower than the corresponding DDD for the ordinary combination due to higher bioavailability.",J01CR04,sultamicillin,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sultamicillin, a prodrug for sulbactam and ampicillin, is lower than the corresponding DDD for the ordinary combination due to higher bioavailability.",J01CR05,piperacillin and beta-lactamase inhibitor,Refers to piperacillin,NA,NA,NA,14,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01C,"BETA-LACTAM ANTIBACTERIALS, PENICILLINS",J01CR,"Combinations of penicillins, incl. beta-lactamase inhibitors","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for sultamicillin, a prodrug for sulbactam and ampicillin, is lower than the corresponding DDD for the ordinary combination due to higher bioavailability.",J01CR50,combinations of penicillins,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB01,cefalexin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB02,cefaloridine,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB03,cefalotin,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB04,cefazolin,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB05,cefadroxil,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB06,cefazedone,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB07,cefatrizine,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB08,cefapirin,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB09,cefradine,NA,NA,NA,2,2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB10,cefacetrile,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB11,cefroxadine,NA,NA,NA,2.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DB,First-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DB12,ceftezole,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC01,cefoxitin,NA,NA,NA,NA,6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC02,cefuroxime,NA,NA,NA,0.5,3,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC03,cefamandole,NA,NA,NA,NA,6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC04,cefaclor,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC05,cefotetan,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC06,cefonicid,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC07,cefotiam,NA,NA,NA,1.2,4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC08,loracarbef,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC09,cefmetazole,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC10,cefprozil,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC11,ceforanide,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC12,cefminox,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC13,cefbuperazone,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC14,flomoxef,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DC,Second-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DC52,cefuroxime and beta-lactamase inhibitor,Refers to cefuroxime,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD01,cefotaxime,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD02,ceftazidime,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD03,cefsulodin,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD04,ceftriaxone,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD05,cefmenoxime,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD06,latamoxef,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD07,ceftizoxime,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD08,cefixime,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD09,cefodizime,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD10,cefetamet,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD11,cefpiramide,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD12,cefoperazone,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD13,cefpodoxime,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD14,ceftibuten,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD15,cefdinir,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD16,cefditoren,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD17,cefcapene,NA,NA,NA,0.45,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD18,cefteram,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD51,cefotaxime and beta-lactamase inhibitor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD52,ceftazidime and beta-lactamase inhibitor,Refers to ceftazidime,NA,NA,NA,6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD54,"ceftriaxone, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD58,cefixime and beta-lactamase inhibitor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD62,cefoperazone and beta-lactamase inhibitor,Refers to cefoperazone,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD63,ceftriaxone and beta-lactamase inhibitor,Refers to ceftriaxone,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DD,Third-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DD64,cefpodoxime and beta-lactamase inhibitor,Refers to cefpodoxime,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DE,Fourth-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DE01,cefepime,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DE,Fourth-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DE02,cefpirome,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DE,Fourth-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DE03,cefozopran,NA,NA,NA,NA,4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DE,Fourth-generation cephalosporins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DE51,cefepime and beta-lactamase inhibitor,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DF,Monobactams,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DF01,aztreonam,NA,NA,0.225,NA,4,NA,NA,g,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DF,Monobactams,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DF02,carumonam,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH02,meropenem,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH03,ertapenem,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH04,doripenem,NA,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH05,biapenem,NA,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH06,tebipenem pivoxil,NA,NA,NA,0.56,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH51,imipenem and cilastatin,Refers to imipenem,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH52,meropenem and vaborbactam,Refers to meropenem,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH55,panipenem and betamipron,Refers to panipenem,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DH,Carbapenems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections. The DDD for meropenem is based on treatment of severe infections.",J01DH56,"imipenem, cilastatin and relebactam",Refers to imipenem,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DI,Other cephalosporins and penems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DI01,ceftobiprole medocaril,NA,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DI,Other cephalosporins and penems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DI02,ceftaroline fosamil,NA,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DI,Other cephalosporins and penems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DI03,faropenem,NA,NA,NA,0.75,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DI,Other cephalosporins and penems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DI04,cefiderocol,NA,NA,NA,NA,6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01D,OTHER BETA-LACTAM ANTIBACTERIALS,J01DI,Other cephalosporins and penems,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The cephalosporins are used in highly variable dosages for different indications, which should be reflected in the assigned DDDs.  The indications for use of the cephalosporins (i.e. the severity of the infections) vary rather extensively from one country to another.  The assigned DDDs are placed in the upper area of the dose range for moderate to severe infections.",J01DI54,ceftolozane and beta-lactamase inhibitor,Refers to ceftolozane,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EA,Trimethoprim and derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. The DDDs are based on the treatment of acute urinary-tract infections.",J01EA01,trimethoprim,NA,NA,NA,0.4,0.4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EA,Trimethoprim and derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. The DDDs are based on the treatment of acute urinary-tract infections.",J01EA02,brodimoprim,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EA,Trimethoprim and derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. The DDDs are based on the treatment of acute urinary-tract infections.",J01EA03,iclaprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB01,sulfaisodimidine,NA,NA,NA,4,4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB02,sulfamethizole,NA,NA,NA,4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB03,sulfadimidine,NA,NA,NA,4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB04,sulfapyridine,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB05,sulfafurazole,NA,NA,NA,4,4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB06,sulfanilamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB07,sulfathiazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB08,sulfathiourea,NA,NA,NA,6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EB,Short-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EB20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EC,Intermediate-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EC01,sulfamethoxazole,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EC,Intermediate-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EC02,sulfadiazine,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EC,Intermediate-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EC03,sulfamoxole,NA,NA,NA,1,1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EC,Intermediate-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01EC20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED01,sulfadimethoxine,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED02,sulfalene,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED03,sulfametomidine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED04,sulfametoxydiazine,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED05,sulfamethoxypyridazine,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED06,sulfaperin,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED07,sulfamerazine,NA,NA,NA,3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED08,sulfaphenazole,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED09,sulfamazone,NA,NA,NA,1.5,NA,1.5,NA,NA,g,NA,g
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01ED,Long-acting sulfonamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting.",J01ED20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE01,sulfamethoxazole and trimethoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE02,sulfadiazine and trimethoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE03,sulfametrole and trimethoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE04,sulfamoxole and trimethoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE05,sulfadimidine and trimethoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE06,sulfadiazine and tetroxoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01E,SULFONAMIDES AND TRIMETHOPRIM,J01EE,"Combinations of sulfonamides and trimethoprim, incl. derivatives","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the sulfonamides are related to the duration of effect, i.e. usually the long-acting sulfonamides will have lower DDDs than the short-acting. When establishing DDDs for combination products, both components are taken into consideration, see list of DDDs for combination products, www.whocc.no.",J01EE07,sulfamerazine and trimethoprim,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA01,erythromycin,erythromycin ethylsuccinate tablets,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA01,erythromycin,NA,NA,NA,1,1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA02,spiramycin,NA,NA,NA,3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA03,midecamycin,NA,NA,NA,1.2,1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA05,oleandomycin,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA06,roxithromycin,NA,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA07,josamycin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA08,troleandomycin,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA09,clarithromycin,NA,NA,NA,0.5,1,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA10,azithromycin,NA,NA,NA,0.3,0.5,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA11,miocamycin,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA12,rokitamycin,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA13,dirithromycin,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA14,flurithromycin,NA,NA,NA,0.75,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA15,telithromycin,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FA,Macrolides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Erythromycin ethylsuccinate tablets have been assigned a higher DDD than other preparations of erythromycin due to a lower bio-availability.  This DDD is mainly based on the dose recommendations.The oral DDD for azithromycin is based on a 5-day regimen.",J01FA16,solithromycin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FF,Lincosamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Orally and parenterally administered clindamycin have different DDDs due to different indications, i.e. the intestinal and systemic infections, respectively.",J01FF01,clindamycin,NA,NA,NA,1.2,1.8,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FF,Lincosamides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Orally and parenterally administered clindamycin have different DDDs due to different indications, i.e. the intestinal and systemic infections, respectively.",J01FF02,lincomycin,NA,NA,NA,1.8,1.8,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FG,Streptogramins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01FG01,pristinamycin,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01F,"MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",J01FG,Streptogramins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01FG02,quinupristin/dalfopristin,NA,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GA,Streptomycins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01GA01,streptomycin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GA,Streptomycins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01GA02,streptoduocin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB01,tobramycin,NA,0.112,0.3,NA,0.24,NA,g,g,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB03,gentamicin,NA,NA,NA,NA,0.24,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB04,kanamycin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB05,neomycin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB06,amikacin,NA,NA,0.59,NA,1,NA,NA,g,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB07,netilmicin,NA,NA,NA,0.35,0.35,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB08,sisomicin,NA,NA,NA,NA,0.24,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB09,dibekacin,NA,NA,NA,NA,0.14,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB10,ribostamycin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB11,isepamicin,NA,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB12,arbekacin,NA,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB13,bekanamycin,NA,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01G,AMINOGLYCOSIDE ANTIBACTERIALS,J01GB,Other aminoglycosides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the aminoglycosides are based on use in severe infections.",J01GB14,plazomicin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA01,ofloxacin,NA,NA,NA,0.4,0.4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA02,ciprofloxacin,NA,NA,NA,1,0.8,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA03,pefloxacin,NA,NA,NA,0.8,0.8,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA04,enoxacin,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA05,temafloxacin,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA06,norfloxacin,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA07,lomefloxacin,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA08,fleroxacin,NA,NA,NA,0.4,0.4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA09,sparfloxacin,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA10,rufloxacin,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA11,grepafloxacin,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA12,levofloxacin,NA,NA,0.24,0.5,0.5,NA,NA,g,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA13,trovafloxacin,NA,NA,NA,0.2,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA14,moxifloxacin,NA,NA,NA,0.4,0.4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA15,gemifloxacin,NA,NA,NA,0.32,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA16,gatifloxacin,NA,NA,NA,0.4,0.4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA17,prulifloxacin,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA18,pazufloxacin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA19,garenoxacin,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA21,sitafloxacin,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA22,tosufloxacin,NA,NA,NA,0.45,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA23,delafloxacin,NA,NA,NA,0.9,0.6,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA24,levonadifloxacin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MA,Fluoroquinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the fluoroquinolones are mainly based on the treatment of respiratory tract infections.The DDDs for pefloxacin, enoxacin and norfloxacin are based on the treatment of complicated urinary tract infections.",J01MA25,lascufloxacin,NA,NA,NA,75,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB01,rosoxacin,NA,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB02,nalidixic acid,NA,NA,NA,4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB03,piromidic acid,NA,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB04,pipemidic acid,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB05,oxolinic acid,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB06,cinoxacin,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB07,flumequine,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01M,QUINOLONE ANTIBACTERIALS,J01MB,Other quinolones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.  The DDD for rosoxacin is based on single dose treatment of gonorrhoea.",J01MB08,nemonoxacin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA01,"penicillins, combinations with other antibacterials",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA02,"sulfonamides, combinations with other antibacterials (excl. trimethoprim)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA03,cefuroxime and metronidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA04,spiramycin and metronidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA05,levofloxacin and ornidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA06,cefepime and amikacin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA07,"azithromycin, fluconazole and secnidazole",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA08,tetracycline and oleandomycin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA09,ofloxacin and ornidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA10,ciprofloxacin and metronidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA11,ciprofloxacin and tinidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA12,ciprofloxacin and ornidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA13,norfloxacin and tinidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA14,norfloxacin and metronidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA15,cefixime and ornidazole,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01R,COMBINATIONS OF ANTIBACTERIALS,J01RA,Combinations of antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01RA16,cefixime and azithromycin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XA,Glycopeptide antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XA01,vancomycin,NA,NA,NA,NA,2,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XA,Glycopeptide antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XA02,teicoplanin,NA,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XA,Glycopeptide antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XA03,telavancin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XA,Glycopeptide antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XA04,dalbavancin,course dose,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XA,Glycopeptide antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XA05,oritavancin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XB,Polymyxins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XB01,colistin,NA,3,3,NA,9,NA,MU,MU,NA,MU,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XB,Polymyxins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XB02,polymyxin B,NA,NA,NA,NA,0.15,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XC,Steroid antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J01XC01,fusidic acid,NA,NA,NA,1.5,1.5,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XD,Imidazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the parenteral imidazole formulations are based on the treatment of anaerobic bacteria infections.",J01XD01,metronidazole,NA,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XD,Imidazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the parenteral imidazole formulations are based on the treatment of anaerobic bacteria infections.",J01XD02,tinidazole,NA,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XD,Imidazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for the parenteral imidazole formulations are based on the treatment of anaerobic bacteria infections.",J01XD03,ornidazole,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XE,Nitrofuran derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.",J01XE01,nitrofurantoin,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XE,Nitrofuran derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.",J01XE02,nifurtoinol,NA,NA,NA,0.16,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XE,Nitrofuran derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.",J01XE03,furazidin,NA,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XE,Nitrofuran derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are generally based on the treatment of acute urinary tract infections.",J01XE51,"nitrofurantoin, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX01,fosfomycin,NA,NA,NA,3,8,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX02,xibornol,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX03,clofoctol,NA,NA,NA,NA,NA,1.5,NA,NA,NA,NA,g
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX04,spectinomycin,NA,NA,NA,NA,3,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX05,methenamine,hippurate,NA,NA,2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX05,methenamine,mandelate,NA,NA,3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX06,mandelic acid,NA,NA,NA,12,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX07,nitroxoline,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX08,linezolid,NA,NA,NA,1.2,1.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX09,daptomycin,NA,NA,NA,NA,0.28,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX10,bacitracin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX11,tedizolid,NA,NA,NA,0.2,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J01,ANTIBACTERIALS FOR SYSTEMIC USE,J01X,OTHER ANTIBACTERIALS,J01XX,Other antibacterials,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The parenteral DDD for fosfomycin is based on the use of a single prophylactic dose in connection with surgery, whilst the oral DDD is based on treatment of uncomplicated lower urinary tract infections given as a single dose of fosfomycin trometamol.The DDD for spectinomycin is based on the use of a single dose for treatment of uncomplicated gonorrhea.The DDD for methenamine is based on prophylaxis of urinary tract infections.  The DDDs for mandelic acid and nitroxoline are based on the treatment of acute urinary tract infections.",J01XX12,lefamulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AA,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Lipid formulations (e.g. liposomal, lipid complex) of amphotericin B have been assigned a separate, higher DDD from the conventional formulations due to a considerably higher dosage.",J02AA01,amphotericin B,lipid formulations,NA,NA,NA,210,NA,NA,NA,NA,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AA,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Lipid formulations (e.g. liposomal, lipid complex) of amphotericin B have been assigned a separate, higher DDD from the conventional formulations due to a considerably higher dosage.",J02AA01,amphotericin B,NA,NA,NA,NA,35,NA,NA,NA,NA,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AA,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). Lipid formulations (e.g. liposomal, lipid complex) of amphotericin B have been assigned a separate, higher DDD from the conventional formulations due to a considerably higher dosage.",J02AA02,hachimycin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AB,Imidazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AB01,miconazole,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AB,Imidazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AB02,ketoconazole,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The oral DDD for posaconazole is based on the recommended dose for gastro-resistant tablets.",J02AC01,fluconazole,NA,NA,NA,0.2,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The oral DDD for posaconazole is based on the recommended dose for gastro-resistant tablets.",J02AC02,itraconazole,NA,NA,NA,0.2,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The oral DDD for posaconazole is based on the recommended dose for gastro-resistant tablets.",J02AC03,voriconazole,NA,NA,NA,0.4,0.4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The oral DDD for posaconazole is based on the recommended dose for gastro-resistant tablets.",J02AC04,posaconazole,NA,NA,NA,0.3,0.3,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The oral DDD for posaconazole is based on the recommended dose for gastro-resistant tablets.",J02AC05,isavuconazole,NA,NA,NA,0.2,0.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AC,Triazole and tetrazole derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The oral DDD for posaconazole is based on the recommended dose for gastro-resistant tablets.",J02AC06,oteseconazole,NA,NA,NA,21,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AX01,flucytosine,NA,NA,NA,10,10,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AX04,caspofungin,NA,NA,NA,NA,50,NA,NA,NA,NA,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AX05,micafungin,NA,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AX06,anidulafungin,NA,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AX07,ibrexafungerp,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J02,ANTIMYCOTICS FOR SYSTEMIC USE,J02A,ANTIMYCOTICS FOR SYSTEMIC USE,J02AX,Other antimycotics for systemic use,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J02AX08,rezafungin acetate,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AA,Aminosalicylic acid and derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AA01,4-aminosalicylic acid,NA,NA,NA,12,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AA,Aminosalicylic acid and derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AA02,sodium aminosalicylate,NA,NA,NA,14,14,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AA,Aminosalicylic acid and derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AA03,calcium aminosalicylate,NA,NA,NA,15,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB01,cycloserine,NA,NA,NA,0.75,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB02,rifampicin,NA,NA,NA,0.6,0.6,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB03,rifamycin,NA,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB04,rifabutin,NA,NA,NA,0.15,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB05,rifapentine,NA,NA,NA,0.11,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB06,enviomycin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AB,Antibiotics,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no. The DDD for rifapentine is based on the first 6 months treatment period, including both the initial phase and the continuous phase.",J04AB30,capreomycin,NA,NA,NA,NA,1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AC,Hydrazides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AC01,isoniazid,NA,NA,NA,0.3,0.3,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AC,Hydrazides,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AC51,"isoniazid, combinations",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AD,Thiocarbamide derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AD01,protionamide,NA,NA,NA,0.75,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AD,Thiocarbamide derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AD02,tiocarlide,NA,NA,NA,7,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AD,Thiocarbamide derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AD03,ethionamide,NA,NA,NA,0.75,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK01,pyrazinamide,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK02,ethambutol,NA,NA,NA,1.2,1.2,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK03,terizidone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK04,morinamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK05,bedaquiline,NA,NA,NA,86,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK06,delamanid,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK07,thioacetazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AK,Other drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AK08,pretomanid,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM01,streptomycin and isoniazid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM02,rifampicin and isoniazid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM03,ethambutol and isoniazid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM04,thioacetazone and isoniazid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM05,"rifampicin, pyrazinamide and isoniazid",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM06,"rifampicin, pyrazinamide, ethambutol and isoniazid",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM07,"rifampicin, ethambutol and isoniazid",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04A,DRUGS FOR TREATMENT OF TUBERCULOSIS,J04AM,Combinations of drugs for treatment of tuberculosis,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in the treatment of tuberculosis. DDDs for combination products see www.whocc.no.",J04AM08,"isoniazid, sulfamethoxazole, trimethoprim and pyridoxine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J04BA01,clofazimine,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J04BA02,dapsone,NA,NA,NA,50,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J04BA03,aldesulfone sodium,NA,NA,NA,0.33,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J04BA50,dapsone and rifampicin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J04,ANTIMYCOBACTERIALS,J04B,DRUGS FOR TREATMENT OF LEPRA,J04BA,Drugs for treatment of lepra,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J04BA51,"dapsone, rifampicin and clofazimine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AA,Thiosemicarbazones,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AA01,metisazone,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB01,aciclovir,NA,NA,NA,4,4,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB02,idoxuridine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB03,vidarabine,NA,NA,NA,NA,0.7,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB06,ganciclovir,NA,NA,NA,3,0.5,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB09,famciclovir,NA,NA,NA,0.75,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB11,valaciclovir,NA,NA,NA,3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB12,cidofovir,NA,NA,NA,NA,25,NA,NA,NA,NA,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB13,penciclovir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB14,valganciclovir,NA,NA,NA,0.9,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB15,brivudine,NA,NA,NA,0.125,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB16,remdesivir,NA,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB17,brincidofovir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AB,Nucleosides and nucleotides excl. reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs for aciclovir, valaciclovir and famciclovir are based on the treatment of herpes zoster infections.The DDD for ganciclovir is based on the treatment of cytomegalovirus infections in immunosuppressed patients.The DDD for cidofovir is based on the treatment of CMV-retinitis in AIDS patients.",J05AB18,molnupiravir,NA,NA,NA,1.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AC,Cyclic amines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AC02,rimantadine,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AC,Cyclic amines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AC03,tromantadine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AD,Phosphonic acid derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for foscarnet is based on the treatment of CMV-retinitis in AIDS patients.",J05AD01,foscarnet,NA,NA,NA,NA,6.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AD,Phosphonic acid derivatives,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for foscarnet is based on the treatment of CMV-retinitis in AIDS patients.",J05AD02,fosfonet,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE01,saquinavir,NA,NA,NA,1.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE02,indinavir,NA,NA,NA,2.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE03,ritonavir,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE04,nelfinavir,NA,NA,NA,2.25,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE05,amprenavir,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE07,fosamprenavir,NA,NA,NA,1.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE08,atazanavir,NA,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE09,tipranavir,NA,NA,NA,1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE10,darunavir,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE16,ensitrelvir,NA,NA,NA,0.175,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AE,Protease inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.The DDD for saquinavir is based on the dose recommendations for hard capsules.",J05AE30,nirmatrelvir and ritonavir,refers to nirmatrelvir,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF01,zidovudine,NA,NA,NA,0.6,0.6,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF02,didanosine,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF03,zalcitabine,NA,NA,NA,2.25,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF04,stavudine,NA,NA,NA,80,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF05,lamivudine,NA,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF06,abacavir,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF07,tenofovir disoproxil,NA,NA,NA,0.245,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF08,adefovir dipivoxil,NA,NA,NA,10,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF09,emtricitabine,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF10,entecavir,NA,NA,NA,0.5,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF11,telbivudine,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF12,clevudine,NA,NA,NA,30,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AF,Nucleoside and nucleotide reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.The DDD for tenofovir disoproxil is 245 mg and is equivalent to 300 mg tenofovir disoproxil fumarat.The DDDs for entecavir and telbivudine are based on monotherapy in the treatment of chronic hepatitis B virus infections.",J05AF13,tenofovir alafenamide,NA,NA,NA,25,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.",J05AG01,nevirapine,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.",J05AG02,delavirdine,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.",J05AG03,efavirenz,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.",J05AG04,etravirine,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.",J05AG05,rilpivirine,NA,NA,NA,25,15,NA,NA,NA,mg,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AG,Non-nucleoside reverse transcriptase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDDs are based on combination therapy in HIV infections.",J05AG06,doravirine,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,Neuraminidase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for oseltamivir is based on the treatment of influenza.",J05AH01,zanamivir,NA,20,NA,NA,1.2,NA,mg,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,Neuraminidase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for oseltamivir is based on the treatment of influenza.",J05AH02,oseltamivir,NA,NA,NA,0.15,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,Neuraminidase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for oseltamivir is based on the treatment of influenza.",J05AH03,peramivir,NA,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AH,Neuraminidase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The DDD for oseltamivir is based on the treatment of influenza.",J05AH04,laninamivir,NA,40,0.16,NA,NA,NA,mg,g,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,Integrase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AJ01,raltegravir,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,Integrase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AJ02,elvitegravir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,Integrase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AJ03,dolutegravir,NA,NA,NA,50,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AJ,Integrase inhibitors,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AJ04,cabotegravir,NA,NA,NA,30,10,NA,NA,NA,mg,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP01,ribavirin,NA,NA,6,1,NA,NA,NA,g,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP02,telaprevir,NA,NA,NA,2.25,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP03,boceprevir,NA,NA,NA,2.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP04,faldaprevir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP05,simeprevir,NA,NA,NA,0.15,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP06,asunaprevir,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP07,daclatasvir,NA,NA,NA,60,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP08,sofosbuvir,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP09,dasabuvir,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP10,elbasvir,NA,NA,NA,50,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP11,grazoprevir,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP12,coblopasvir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP13,ravidasvir,NA,NA,NA,0.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP51,sofosbuvir and ledipasvir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP52,"dasabuvir, ombitasvir, paritaprevir and ritonavir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP53,"ombitasvir, paritaprevir and ritonavir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP54,elbasvir and grazoprevir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP55,sofosbuvir and velpatasvir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP56,"sofosbuvir, velpatasvir and voxilaprevir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP57,glecaprevir and pibrentasvir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AP,Antivirals for treatment of HCV infections,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). The inhalation DDD for ribavirin is based on the treatment of respiratory syncytial viral (RSV) infections in neonates and infants.",J05AP58,"daclatasvir, asunaprevir and beclabuvir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR01,zidovudine and lamivudine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR02,lamivudine and abacavir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR03,tenofovir disoproxil and emtricitabine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR04,"zidovudine, lamivudine and abacavir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR05,"zidovudine, lamivudine and nevirapine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR06,"emtricitabine, tenofovir disoproxil and efavirenz",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR07,"stavudine, lamivudine and nevirapine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR08,"emtricitabine, tenofovir disoproxil and rilpivirine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR09,"emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR10,lopinavir and ritonavir,Refers to lopinavir,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR11,"lamivudine, tenofovir disoproxil and efavirenz",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR12,lamivudine and tenofovir disoproxil,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR13,"lamivudine, abacavir and dolutegravir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR14,darunavir and cobicistat,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR15,atazanavir and cobicistat,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR16,lamivudine and raltegravir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR17,emtricitabine and tenofovir alafenamide,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR18,"emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR19,"emtricitabine, tenofovir alafenamide and rilpivirine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR20,"emtricitabine, tenofovir alafenamide and bictegravir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR21,dolutegravir and rilpivirine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR22,"emtricitabine, tenofovir alafenamide, darunavir and cobicistat",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR23,atazanavir and ritonavir,Refers to atazanavir,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR24,"lamivudine, tenofovir disoproxil and doravirine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR25,lamivudine and dolutegravir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR26,darunavir and ritonavir,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR27,"lamivudine, tenofovir disoproxil and dolutegravir",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AR,"Antivirals for treatment of HIV infections, combinations","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). See list of DDDs for combination products, www.whocc.no.",J05AR28,stavudine and lamivudine,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX01,moroxydine,NA,NA,NA,0.3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX02,lysozyme,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX05,inosine pranobex,NA,NA,NA,3,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX06,pleconaril,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX07,enfuvirtide,NA,NA,NA,NA,0.18,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX09,maraviroc,NA,NA,NA,0.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX10,maribavir,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX13,umifenovir,NA,NA,NA,0.8,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX17,enisamium iodide,NA,NA,NA,1.5,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX18,letermovir,NA,NA,NA,0.48,0.48,NA,NA,NA,g,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX19,tilorone,NA,NA,NA,0.125,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX21,pentanedioic acid imidazolyl ethanamide,NA,NA,NA,90,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX23,ibalizumab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX24,tecovirimat,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX25,baloxavir marboxil,NA,NA,NA,40,NA,NA,NA,NA,mg,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX26,amenamevir,NA,NA,NA,0.4,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX27,favipiravir,NA,NA,NA,1.6,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX28,bulevirtide,NA,NA,NA,NA,2,NA,NA,NA,NA,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX29,fostemsavir,NA,NA,NA,1.2,NA,NA,NA,NA,g,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J05,ANTIVIRALS FOR SYSTEMIC USE,J05A,DIRECT ACTING ANTIVIRALS,J05AX,Other antivirals,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).",J05AX31,lenacapavir,NA,NA,NA,0.19,5.1,NA,NA,NA,g,mg,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06A,IMMUNE SERA,J06AA,Immune sera,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06AA01,diphtheria antitoxin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06A,IMMUNE SERA,J06AA,Immune sera,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06AA02,tetanus antitoxin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06A,IMMUNE SERA,J06AA,Immune sera,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06AA03,snake venom antiserum,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06A,IMMUNE SERA,J06AA,Immune sera,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06AA04,botulinum antitoxin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06A,IMMUNE SERA,J06AA,Immune sera,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06AA05,gas-gangrene sera,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06A,IMMUNE SERA,J06AA,Immune sera,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06AA06,rabies serum,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BA,"Immunoglobulins, normal human","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BA01,"immunoglobulins, normal human, for extravascular adm.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BA,"Immunoglobulins, normal human","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BA02,"immunoglobulins, normal human, for intravascular adm.",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB01,anti-D (rh) immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB02,tetanus immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB03,varicella/zoster immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB04,hepatitis B immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB05,rabies immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB06,rubella immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB07,vaccinia immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB08,staphylococcus immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB09,cytomegalovirus immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB10,diphtheria immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB11,hepatitis A immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB12,"encephalitis, tick borne immunoglobulin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB13,pertussis immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB14,measles immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB15,mumps immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB19,anthrax immunoglobulin,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BB,Specific immunoglobulins,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BB30,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BC01,nebacumab,NA,NA,NA,NA,0.1,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BC02,raxibacumab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BC03,bezlotoxumab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BC,Antibacterial monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BC04,obiltoxaximab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD01,palivizumab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD02,motavizumab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD03,tixagevimab and cilgavimab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD04,ansuvimab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD05,sotrovimab,NA,NA,NA,NA,0.5,NA,NA,NA,NA,g,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD06,regdanvimab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD07,casirivimab and imdevimab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J06,IMMUNE SERA AND IMMUNOGLOBULINS,J06B,IMMUNOGLOBULINS,J06BD,Antiviral monoclonal antibodies,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned, with a few exceptions.",J06BD08,nirsevimab,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AC,Anthrax vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AC01,anthrax antigen,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AD,Brucellosis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AD01,brucella antigen,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AE,Cholera vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AE01,"cholera, inactivated, whole cell",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AE,Cholera vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AE02,"cholera, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AE,Cholera vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AE51,"cholera, combinations with typhoid vaccine, inactivated, whole cell",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AF,Diphtheria vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AF01,diphtheria toxoid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AG,Haemophilus influenzae B vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AG01,"haemophilus influenzae B, purified antigen conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AG,Haemophilus influenzae B vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AG51,"haemophilus influenzae B, combinations with toxoids",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AG,Haemophilus influenzae B vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AG52,"haemophilus influenzae B, combinations with pertussis and toxoids",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AG,Haemophilus influenzae B vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AG53,"haemophilus influenzae B, combinations with meningococcus C, conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AG,Haemophilus influenzae B vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AG54,"haemophilus influenza B, combinations with meningococcus C,Y, conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH01,"meningococcus A, purified polysaccharides antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH02,other meningococcal monovalent purified polysaccharides antigen,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH03,"meningococcus A,C, bivalent purified polysaccharides antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH04,"meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH05,other meningococcal polyvalent purified polysaccharides antigen,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH06,"meningococcus B, outer membrane vesicle vaccine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH07,"meningococcus C, purified polysaccharides antigen conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH08,"meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH09,"meningococcus B, multicomponent vaccine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AH,Meningococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AH10,"meningococcus A, purified polysaccharides antigen conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AJ,Pertussis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AJ01,"pertussis, inactivated, whole cell",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AJ,Pertussis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AJ02,"pertussis, purified antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AJ,Pertussis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AJ51,"pertussis, inactivated, whole cell, combinations with toxoids",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AJ,Pertussis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AJ52,"pertussis, purified antigen, combinations with toxoids",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AK,Plague vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AK01,"plague, inactivated, whole cell",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AL,Pneumococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AL01,"pneumococcus, purified polysaccharides antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AL,Pneumococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AL02,"pneumococcus, purified polysaccharides antigen conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AL,Pneumococcal vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AL52,"pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AM,Tetanus vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AM01,tetanus toxoid,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AM,Tetanus vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AM51,"tetanus toxoid, combinations with diphtheria toxoid",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AM,Tetanus vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AM52,"tetanus toxoid, combinations with tetanus immunoglobulin",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AN,Tuberculosis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AN01,"tuberculosis, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AP,Typhoid vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AP01,"typhoid, oral, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AP,Typhoid vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AP02,"typhoid, inactivated, whole cell",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AP,Typhoid vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AP03,"typhoid, purified polysaccharide antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AP,Typhoid vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AP10,"typhoid, combinations with paratyphi types",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AR,Typhus (exanthematicus) vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AR01,"typhus exanthematicus, inactivated, whole cell",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07A,BACTERIAL VACCINES,J07AX,Other bacterial vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07AX01,leptospira vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BA,Encephalitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BA01,"encephalitis, tick borne, inactivated, whole virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BA,Encephalitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BA02,"encephalitis, Japanese, inactivated, whole virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BA,Encephalitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BA03,"encephalitis, Japanese, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BB,Influenza vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BB01,"influenza, inactivated, whole virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BB,Influenza vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BB02,"influenza, inactivated, split virus or surface antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BB,Influenza vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BB03,"influenza, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BB,Influenza vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BB04,"influenza, virus like particles",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BC,Hepatitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BC01,"hepatitis B, purified antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BC,Hepatitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BC02,"hepatitis A, inactivated, whole virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BC,Hepatitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BC20,combinations,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BD,Measles vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BD01,"measles, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BD,Measles vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BD51,"measles, combinations with mumps, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BD,Measles vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BD52,"measles, combinations with mumps and rubella, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BD,Measles vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BD53,"measles, combinations with rubella, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BD,Measles vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BD54,"measles, combinations with mumps, rubella and varicella, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BE,Mumps vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BE01,"mumps, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BF,Poliomyelitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BF01,"poliomyelitis oral, monovalent, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BF,Poliomyelitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BF02,"poliomyelitis oral, trivalent, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BF,Poliomyelitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BF03,"poliomyelitis, trivalent, inactivated, whole virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BF,Poliomyelitis vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BF04,"poliomyelitis oral, bivalent, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BG,Rabies vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BG01,"rabies, inactivated, whole virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BH,Rota virus diarrhea vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BH01,"rota virus, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BH,Rota virus diarrhea vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BH02,"rota virus, pentavalent, live, reassorted",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BJ,Rubella vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BJ01,"rubella, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BJ,Rubella vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BJ51,"rubella, combinations with mumps, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BK,Varicella zoster vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BK01,"varicella, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BK,Varicella zoster vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BK02,"zoster, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BK,Varicella zoster vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BK03,"zoster, purified antigen",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BL,Yellow fever vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BL01,"yellow fever, live attenuated",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BM,Papillomavirus vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BM01,"papillomavirus (human types 6, 11, 16, 18)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BM,Papillomavirus vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BM02,"papillomavirus (human types 16, 18)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BM,Papillomavirus vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BM03,"papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BN,Covid-19 vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BN01,"covid-19, RNA-based vaccine",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BN,Covid-19 vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BN02,"covid-19, viral vector, non-replicating",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BN,Covid-19 vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BN03,"covid-19, inactivated virus",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BN,Covid-19 vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BN04,"covid-19, protein subunit",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BN,Covid-19 vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BN05,"covid-19, virus-like particles",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BX,Other viral vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BX01,smallpox and monkeypox vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BX,Other viral vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BX02,ebola vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BX,Other viral vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BX04,dengue virus vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BX,Other viral vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BX05,respiratory syncytial virus vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07B,VIRAL VACCINES,J07BX,Other viral vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07BX06,enterovirus 71 vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA01,diphtheria-poliomyelitis-tetanus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA02,diphtheria-pertussis-poliomyelitis-tetanus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA03,diphtheria-rubella-tetanus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA04,haemophilus influenzae B and poliomyelitis,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA05,diphtheria-hepatitis B-pertussis-tetanus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA06,diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA07,diphtheria-hepatitis B-tetanus,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA08,haemophilus influenzae B and hepatitis B,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA09,diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA10,typhoid-hepatitis A,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA11,diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA12,diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07C,"BACTERIAL AND VIRAL VACCINES, COMBINED",J07CA,"Bacterial and viral vaccines, combined","The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07CA13,diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
J,ANTIINFECTIVES FOR SYSTEMIC USE,J07,VACCINES,J07X,OTHER VACCINES,J07XA,Parasitic vaccines,"The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity.  However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly.  The DDDs assigned are based on daily treatment.  The duration of the treatment periods is not taken into consideration.  For antiinfectives given in a high initially starting dose followed by a lower daily ""maintenance"" dose, the DDDs are based on the ""maintenance"" dose if the total duration of the treat-ment course is more than one week.  If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin). No DDDs have been assigned.",J07XA01,malaria vaccines,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
